Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 17 Pain 16 Cancer Pain 14 Pain, Postoperative 9 Chronic Pain 7 Agnosia 5 Colonic Neoplasms 4 Multiple Myeloma 3 Mucositis 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Breast Neoplasms 3 Wounds and Injuries 2 Waldenstrom Macroglobulinemia 2 Thrombocythemia, Essential 2 Supratentorial Neoplasms 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Polycythemia Vera 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Pancreatic Neoplasms 2 Pain, Intractable 2 Neoplastic Cells, Circulating 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡